MedPath
HSA Approval

STORILAT 200 TABLET 200 mg

SIN05583P

STORILAT 200 TABLET 200 mg

STORILAT 200 TABLET 200 mg

February 18, 1991

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Therapeutic

Prescription Only

Formulation Information

TABLET

ORAL

Medical Information

N03AF01

carbamazepine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CARBAMAZEPINE

200 mg

Carbamazepine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STORILAT 200 TABLET 200 mg - HSA Approval | MedPath